| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adrenoceptors as potential target for add-on immunomodulatory therapy in multiple sclerosis
|
Pilipović, Ivan
|
|
|
243 |
C |
p.
|
article
|
| 2 |
BET proteins: Biological functions and therapeutic interventions
|
Guo, Jiawei
|
|
|
243 |
C |
p.
|
article
|
| 3 |
Corrigendum to “Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer” [Pharmacology & Therapeutics 239 (2022) 108296]
|
Liu, Xinlin
|
|
|
243 |
C |
p.
|
article
|
| 4 |
Editorial Board
|
|
|
|
243 |
C |
p.
|
article
|
| 5 |
How to get rid of itching
|
Vander Does, Ashley
|
|
|
243 |
C |
p.
|
article
|
| 6 |
Ifosfamide - History, efficacy, toxicity and encephalopathy
|
Idle, Jeffrey R.
|
|
|
243 |
C |
p.
|
article
|
| 7 |
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets
|
Yang, Liu
|
|
|
243 |
C |
p.
|
article
|
| 8 |
Mechanisms of skeletal muscle-tendon development and regeneration/healing as potential therapeutic targets
|
Yoshimoto, Yuki
|
|
|
243 |
C |
p.
|
article
|
| 9 |
The controversial role of beta-blockers in heart failure with preserved ejection fraction
|
Wernhart, Simon
|
|
|
243 |
C |
p.
|
article
|
Journal description